Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.

ABSTRACT: BACKGROUND:Rett syndrome (RTT) is a pervasive developmental disorder that is progressive and has no effective cure. Immune dysregulation, oxidative stress, and excess glutamate in the brain mediated by glial dysfunction have been implicated in the pathogenesis and worsening of symptoms of RTT. In this study, we investigated a new nanotherapeutic approach to target glia for attenuation of brain inflammation/injury both in vitro and in vivo using a Mecp2-null mouse model of Rett syndrome. METHODS:To determine whether inflammation and immune dysregulation were potential targets for dendrimer-based therapeutics in RTT, we assessed the immune response of primary glial cells from Mecp2-null and wild-type (WT) mice to LPS. Using dendrimers that intrinsically target activated microglia and astrocy

SUBMITTER: Nance E 

PROVIDER: S-EPMC5735803 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature